ABOUT
Vision · Mission · Team
Making Breakthrough Discoveries
with Stealth-Body Technology
CrossPoint Therapeutics is a biotechnology company
founded in October 2022. We aim to become a leader
in the development of new drugs using our proprietary
Stealth-Body technology while
prioritizing the well-being of the patient.
We strive to develop novel treatment options to
refractory diseases with high unmet clinical demand
using our antibody technology to provide
a life free of suffering to patients.
Vision & Mission
Key to the success of
novel drug development
Creative
in Application
Integrity
in Science
Evolution
in Technology
Fast
to Market
CrossPoint Therapeutics strives to develop drugs
that expands the range of curable disease as well as
providing dignity and better life to patients.
We will diversify our Fc inert antibody platform into
various drug modalities to target indications that
are challenging and in desperate need for therapeutics.
To accomplish this mission,
we are always open to actively collaborate.
